Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). Ferreira JP, Cleland JGF, Girerd N, Pellicori P, et al. Am J Cardiol 2023;191:39-42.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ferreira JP, Cleland JGF, Girerd N, Pellicori P, et al. Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). Am J Cardiol 2023;191:39-42.
PMID: 36634548